Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

ARDS Prediction Score in Critically Ill Patients in China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02174081
Recruitment Status : Completed
First Posted : June 25, 2014
Last Update Posted : June 28, 2016
Sponsor:
Information provided by (Responsible Party):
Jianfeng Xie, Southeast University, China

Tracking Information
First Submitted Date June 11, 2014
First Posted Date June 25, 2014
Last Update Posted Date June 28, 2016
Study Start Date March 2014
Actual Primary Completion Date March 2016   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 23, 2014)
incidence of ARDS [ Time Frame: up to 24 months ]
evaluate the incidence of risk factors of ARDS
Original Primary Outcome Measures Same as current
Change History
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title ARDS Prediction Score in Critically Ill Patients in China
Official Title ARDS Prediction Score in Critically Ill Patients in China
Brief Summary ARDS is a severe disease, it's important to predict the incidence of ARDS.
Detailed Description From January 1 to January 31, 2012 and from January 1 to January 10, 2013 , all patients admit to the ICUs will be enrolled. The demographic characteristics, diagnosis, formerly medical history, Ventilator indications, Ventilator data, other respiratory treatments, weaning outcome and 28 day mortality will be recorded.
Study Type Observational
Study Design Observational Model: Cohort
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Probability Sample
Study Population patients have the risk of ARDS
Condition
  • ARDS
  • Septic Shock
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Actual Enrollment
 (submitted: June 27, 2016)
698
Original Estimated Enrollment
 (submitted: June 23, 2014)
1
Actual Study Completion Date June 2016
Actual Primary Completion Date March 2016   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

Critically ill patients who admitted into participating ICU

Exclusion Criteria:

Patients with chronic pulmonary disease such as chronic obstructive pulmonary disease (COPD), asthma, lung cancer, pulmonary fibrosis and tuberculosis Age less than 18 years old Pregnancy Died within 24 hours from ICU admission ARDS patients who diagnosed 24hours before ICU admission Referral from other hospital to participating ICU Lack of data of ARDS risk factors

Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years to 80 Years   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries China
Removed Location Countries  
 
Administrative Information
NCT Number NCT02174081
Other Study ID Numbers ARDS Prediction system
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Jianfeng Xie, Southeast University, China
Study Sponsor Jianfeng Xie
Collaborators Not Provided
Investigators
Principal Investigator: Jianfeng Xie, Dr Southeast University
PRS Account Southeast University, China
Verification Date June 2016